• WAY-100635: Selective 5-HT1A Antagonist

  2026-08-21

  WAY-100635 is a potent, selective, silent 5-HT1A receptor antagonist for serotonin receptor antagonist research and neuroscience receptor pharmacology. Its binding, functional, behavioral, and imaging-research profiles support use as a mechanistic tool rather than as a therapeutic or diagnostic product.

• Protein A/G Magnetic Co-IP/IP Kit Workflow

  2026-08-21

  Build faster, cleaner immunoprecipitation workflows for protein complexes, antibody purification, and IP–MS discovery. This guide translates AP2-M parasite biology into practical assay design, control selection, and troubleshooting using magnetic separation.

• SmD2 Acetylation Tunes HCC PARP Inhibitor Response

  2026-08-20

  This study identifies the spliceosome core protein SmD2 as an acetylation-regulated determinant of DNA damage repair and PARP inhibitor sensitivity in hepatocellular carcinoma. By linking p300/HDAC2-dependent SmD2 stability to BRCA1 and FANC cassette-exon regulation, the work supports spliceosome-directed combination strategies for HCC, including HDAC and PARP inhibition.

• Machine Learning Detects Senescence in Glioblastoma

  2026-08-20

  A bioRxiv preprint presents an imaging-based machine learning pipeline that recognises senescent glioblastoma cells using only DAPI nuclear staining. By applying the classifier to existing high-throughput drug-screening images and experimentally testing predictions, the study demonstrates a scalable route for identifying senescence-inducing compounds.

• Crizotinib Hydrochloride in Tumor Assembloids

  2026-08-19

  Crizotinib hydrochloride can function as more than an ALK kinase inhibitor in advanced tumor models: it can help separate cancer-cell-intrinsic signaling from stromal protection. This article translates patient-derived gastric cancer assembloid findings into a practical framework for target engagement, response decomposition, and assay design.

• Alosetron in Intestinal Signaling Research

  2026-08-19

  Use Alosetron as a selective 5-HT3 receptor antagonist to separate serotonin-dependent effects on epithelial behavior, gastrointestinal motility modulation, and visceral pain signaling from the CDC42–YAP–mTOR mechanisms that control intestinal stem cell fate. This article provides a practical organoid and epithelial workflow, assay controls, and troubleshooting guidance for hypothesis-driven gastrointestinal research.

• SGC-CBP30 for CREBBP/EP300 Bromodomain Studies

  2026-08-18

  SGC-CBP30 provides a selective chemical handle for testing how CREBBP and EP300 bromodomains influence enhancer-driven transcription, TGF-β/SMAD3 signaling, and cancer phenotypes. This workflow translates the LINC01977 super-enhancer findings into practical chromatin, transcriptional, and functional assays while emphasizing controls and troubleshooting.

• Thrombin B-Chain Fragment: Assay Design Guide

  2026-08-17

  Thrombin B-chain fragment A1057 is a sequence-defined reagent for rigorous protease and molecular assays. This guide explains how to distinguish fragment identity from intact enzyme activity and applies lessons from a SARS-CoV-2 3CLpro screening study to assay design.

• AI-10-49: CBFβ-SMMHC Inhibitor Workflow

  2026-08-17

  AI-10-49 enables mechanism-first studies of inv(16) acute myeloid leukemia by separating CBFβ-SMMHC–RUNX1 target engagement from downstream survival effects. This practical guide connects compound handling, leukemia-cell assays, chromatin immunoprecipitation, transcriptional readouts, and in vivo validation into one troubleshooting-ready workflow.

• SM-102: From Lipid Identity to LNP Decisions

  2026-08-16

  SM-102 is an ionizable lipid used in mRNA delivery and mRNA vaccine development. This evidence-led guide connects its chemical and handling profile with machine-learning-guided formulation decisions, clarifying what the literature supports and what still requires experimental validation.

• CDC42 Polarity Controls Intestinal Stem Cell Fate

  2026-08-15

  Zhang et al. show that CDC42-dependent apical-basal polarity regulates the intestinal stem cell-to-transit-amplifying cell transition through a YAP/TAZ–Ereg–EGFR–mTOR cascade rather than canonical Wnt signaling. Genetic epistasis and pharmacological rescue experiments connect epithelial architecture with crypt proliferation and provide a framework for studying intestinal homeostasis in vivo.

• RNA Clean and Concentrator Kit for SVA RNA Assays

  2026-08-14

  The RNA Clean and Concentrator Kit converts in vitro transcription products into cleaner, more reproducible inputs for IRES reporters, RNA pull-downs, and viral RNA studies. Its membrane workflow removes NTPs, proteins, salts, and short oligonucleotides while supporting RNA inputs from 1 ng to 500 μg.

• Z-LEHD-FMK and Viral Pyroptosis Assay Design

  2026-08-14

  Discover how Z-LEHD-FMK, an irreversible caspase-9 inhibitor, can help dissect the transition between mitochondrial apoptosis and GSDME-mediated pyroptosis in avian virus models, with practical guidance for assay design and interpretation.

• EF-P Phosphorylation and S. suis BBB Injury

  2026-08-13

  Yin et al. identify a phosphorylation-dependent virulence mechanism in which the S. suis kinase STK modifies EF-P and enhances serine protease production, leading to blood–brain barrier injury. Mutational, infection-model, and complementation experiments connect the STK/EF-P/SP axis to ZO-1 degradation and provide a mechanistic framework for studying bacterial protein phosphorylation signaling.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-08-13

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, or otherwise difficult DNA templates, producing blunt-ended products. It is not the right choice when a workflow requires 3′-A overhangs or pre-formed sticky ends, and reaction conditions should be validated for each template.

585 records 1/39 page Next 12345 下5页 Last page